GlaxoSmithKline GmbH & Co. KG secures contract for Pharmaceutical products - drug discount agreement in accordance with Section 130a Paragraph 8 SGB V i V m Section 130c Paragraph 1 SGB V for the active ingredient depemokimab

Germany, May 13 -- Germany based GlaxoSmithKline GmbH & Co. KG has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130a Paragraph 8 SGB V i V m Section 130c Paragraph 1 SGB V for the active ingredient depemokimab. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....